Herceptin (trastuzumab) is a monoclonal antibody remedy used to deal with HER2-positive breast most cancers. It’s a focused remedy that works by blocking the HER2 protein, which is discovered on the floor of most cancers cells. Herceptin can be utilized to deal with early-stage and advanced-stage breast most cancers, and it may be utilized in mixture with different chemotherapy medication or as a single agent.
Herceptin was accredited by the U.S. Meals and Drug Administration (FDA) in 1998, and it has since turn out to be one of the extensively used most cancers medication on the earth. It has been proven to be efficient in bettering survival charges and decreasing the danger of recurrence in ladies with HER2-positive breast most cancers. Herceptin is mostly well-tolerated, however it may well trigger uncomfortable side effects resembling diarrhea, nausea, and fatigue. Herceptin is on the market in each intravenous (IV) and subcutaneous (SC) formulations.
